tm logo
VYRALM
ABANDONED SECTION 36

on 29 Dec 2023

Last Applicant/ Owned by

ALLOVIR INC.

1100 Winter StreetWaltham, MA 02451

US

Serial Number

2017761 filed on 16th Mar 2020

Correspondent Address

SUITE 1000, 55 METCALFE STREETP.O. BOX 2999, STATION DOttawa

ONTARIO

CA

K1P5Y6

VYRALM

Trademark usage description

cell growth media for growing cells for medical or clinical use; cells for medical or clinical use; pharmaceutical products for the prevention and tre Read More

Classification Information


Class [005]
Cell growth media for growing cells for medical or clinical use; Cells for medical or clinical use; Pharmaceutical products for the prevention and treatment of cancer; Pharmaceutical products for the treatment of bone diseases; Pharmaceutical products for the treatment of cancer; Pharmaceutical products for the treatment of viral and infectious diseases, for the treatment of cancer; Pharmaceutical products for treating respiratory diseases; Pharmaceutical products for treating respiratory diseases and asthma; Pharmaceutical preparations and substances for the treatment of viral, metabolic, endocrine, musculoskeletal, cardiovascular, cardiopulmonary, genitourinary, sexual dysfunction, oncological, hepatological, ophthalmic, respiratory, neurological, gastrointestinal, hormonal, dermatological, psychiatric and immune system related diseases and disorders; Pharmaceutical preparations for the treatment of immune system related diseases and disorders


Classification kind code

11

Mark Details


Serial Number

2017761

Mark Type

Trademark

Legal History


Show more

Action TakenStatus
Submitted for opposition 14
on 11th Oct 2023
Default Notice Sent
Submitted for opposition 67
on 29th Sep 2023
Agent Name Changed
Submitted for opposition 135
on 29th Jun 2023
Amendment to Application
Submitted for opposition 20
on 20th Mar 2023
Examiner's First Report
Submitted for opposition 22
on 19th Mar 2023
Search Recorded
Submitted for opposition 287
on 14th Apr 2022
Pre-Assessment Letter Sent
Submitted for opposition 48
on 13th Jan 2022
Agent Changed
Submitted for opposition 30
on 16th Mar 2020
Filed
Submitted for opposition 1
on 16th Mar 2020
Created
Submitted for opposition 31
on 16th Mar 2020
Formalized